Outcomes4Me Inc., the leading direct-to-patient health technology company leveraging AI to revolutionize cancer care, announces it has completed its acquisitions of two innovative platforms: Geno.Me, a platform that bridges the gap between patient data and researchers, and Realyze Intelligence, an AI clinical trial matching platform integrated into clinical workflows, initially developed at UPMC. These technologies, combined with Outcomes4Me’s existing patient empowerment capabilities, will further support the company’s work to help patients with cancer gain access to the latest, evidence-based and personalized treatment options and clinical trials.
Read the full article: Outcomes4Me Acquires Geno.Me and Realyze Intelligence //
Source: https://www.prnewswire.com/news-releases/outcomes4me-acquires-genome-and-realyze-intelligence-names-upmc-hillman-cancer-center-cio-as-strategic-advisor-to-expedite-ai-driven-cancer-care-and-clinical-trial-access-302779191.html